Valrubicin

Overview
Catalog #	bs-6808c-10mg-solid
Product Name	Valrubicin
Specifications
Storage Buffer	Powder
Storage Condition	Store in dry, dark place at -20C for 1 year.
Target
Product Information	Molecular Weight: 723.64 Formula: C34 H36 F3 N O13 CAS Number: 56124-62-0 InChi Key: ZOCKGBMQLCSHFP-PIXAVGEUSA-N InChi: InChI=1S/C34H36F3NO13/c1-4-5-9-21(40)49-13-20(39)33(47)11-16-24(19(12-33)51-22-10-17(27(41)14(2)50-22)38-32(46)34(35,36)37)31(45)26-25(29(16)43)28(42)15-7-6-8-18(48-3)23(15)30(26)44/h6-8,14,17,19,22,27,41,43,45,47H,4-5,9-13H2,1-3H3,(H,38,46)/t14-,17-,19-,22+,27+,33-/m0/s1 Smiles: C[C@@H]1O[C@@H](C[C@H](NC(=O)C(F)(F)F)[C@@H]1O)O[C@H]1C[C@@](O)(CC2C1=C(O)C1=C(C(=O)C3=CC=CC(OC)=C3C1=O)C=2O)C(=O)COC(=O)CCCC Purity: 98.0 Solubility: Soluble in DMSO, not in water Appearance: Red solid powder Shelf Life: 1.0 years
Description	Valrubicin is a semisynthetic derivative of the antineoplastic anthracycline antibiotic doxorubicin. With a mechanism of action that appears to differ from doxorubicin, valrubicin is converted intracytoplasmically into N-trifluoroacetyladriamycin, which interacts with topoisomerase II, stabilizing the complex between the enzyme and DNA; consequently, DNA replication and repair and RNA and protein synthesis are inhibited and the cell cycle is arrested in the G2 phase. In addition, this agent accumulates in the cell cytoplasm where it inhibits protein kinase C (PKC). Valrubicin is less cardiotoxic than doxorubicin when administered systemically; applied topically, this agent shows excellent tissue penetration.